The GLP-1 story is often framed as substitution: medication in, surgery and traditional programs out. National audience data tells a more layered story, revealing four distinct weight-loss audiences, a growing telehealth segment disconnected from primary care, and a timely wrinkle as employer coverage starts to pull back.